Table 2.
Items of primary concern and secondary concern for analyses
| Primary concern | Secondary concern |
|---|---|
| 1. Malignancy/other |
1. Objective |
| 2. Genomic information |
2. Developmental phase |
| 3. Confirmatory/exploratory |
3. Randomization unit |
| 4. Explanatory/pragmatic |
4. Stratification |
| 5. Basic design |
5. Dynamic allocation |
| 6. Randomization |
6. Institution consideration in allocation |
| 7. Blinding |
7. Concealment |
| 8. Control |
8. Blocking in allocation |
| 9. Number of arms |
9. Purpose of intervention |
| 10. Type of intervention |
10. Lower age limit |
| 11. Target sample size |
11. Sex |
| 12. Trial period |
12. Primary sponsor |
| 13. Publication of results |
13. Funding source |
| 14. Disclosure of trial before/after trial start |
|
| 15. Disease classification by specialty |